header-image

Quality Control of Raw Materials (APIs and Excipients)

Im Auftrag der European Compliance Academy

1-2 February 2017, Barcelona, Spain

Seminar-Nr. 15563

Sprecher

Emerich Grassinger, Haupt Pharma Wülfing


Armin Groh, Takeda

Dr Reto Theiß, Merck

Dr Thomas Storm, Novartis Pharma

Zielsetzung

Testing active pharmaceutical ingredients and excipients is one of the main tasks of the quality control units in the pharmaceutical industry. It must be ensured that the necessary tests are conducted on the incoming goods and that the starting materials are released only after their quality was judged as satisfactory. This GMP Education Course about the incoming goods control of APIs and excipients will give you a comprehensive overview of the specific tasks and questions of the „raw materials lab“ and show you real-life solutions and answers.

This course will deal among others with the following questions:

  • Who is responsible for the release or rejection of starting materials?
  • How can the incoming goods lab be organised efficiently?
  • Which SOPs are necessary?
  • In which cases can test results be taken over from the supplier‘s certificate of analysis?
  • Do all test items of a pharmacopoeial monograph have to be analysed?
  • Are the pharmacopoeial monographs similar, or must different tests be conducted for PhEur, USP and JP?
  • Can a pharmacopoeial test method be replaced by an alternative test method? Does this require a variation application?
It is the aim of this GMP Education Course to give answers to these and many other important questions relating to the testing of APIs and excipients and to serve as a forum for an intensive experience exchange.

Zielgruppe

This Education Course is directed at all those employees from quality control units in the pharmaceutical industry (including heads of quality control and laboratory managers) who are competent or responsible for sampling, testing and release of the starting materials used (= APIs and excipients).

This course is also of interest to personnel from quality assurance and to those employees from API and excipient manufacturers who want to inform themselves about the requirements of the pharmaceutical industry on the testing of these starting materials.

Programm

Regulatory Requirements for APIs and Excipients

  • Definition of APIs and excipients
  • EU Requirements
  • FDA Requirements, e.g. FDA Draft Guidance “Drug Product”
  • Common Technical Document (CTD)
  • Certification Procedures: EDQM Certificate of Suitability, Active Substance Master File, US-Drug Master File
  • Quality Standard: How to discern a good starting material from a bad one?
Current GMP Requirements for APIs, Excipients and Drug Products
  • Relevant ICH guidelines
  • EU regulations for Drug Products and API
  • GMP for excipients – current expectations
  • IPEC (International Pharmaceutical Excipients Council) Guideline for excipients
  • Upcoming EU GMP regulation for excipients
  • GMP aspects of supplier/manufacturer qualification
Laboratory Organisation
  • Role of the raw materials laboratory within the pharmaceutical supply chain
  • Optimization of the analytical laboratory with respect to costs, time and resources (economic order size, costs of analysis vs stock keeping costs, involvement of RM suppliers in the SC)
Pharmacopoeias
  • Regulatory background
  • Pharmacopoeial institutions – Ph.Eur., USP/NF, JP
  • CEPs
  • Implementation of pharmacopoeial monographs in your laboratory
  • Multi-compendial testing
  • Validation of pharmacopoeial testing methods
  • New USP General Chapter <1226> Verification of Compendial Methods
Sampling of Incoming APIs and Excipients
  • Regulatory requirements
  • Are the requirements the same for active and excipients?
  • Sampling plans
  • Training
  • GMP-compliant documentation of sampling operations
  • Practical examples
Reduced Testing of Supplied APIs and Excipients
  • What guidance is available on reduced QC testing?
  • EU and FDA expectations?
  • Supplier qualification as a prerequisite
  • Other information required before you start reducing
  • Can APIs and excipients be covered within the same approach?
  • Who is in the driver seat, who must be involved?
  • Practical execution
Analytical Methods
  • Use and validation of non-compendial methods
  • How to proof comparability?
  • Advantages of instrumental methods versus visual methods
  • Handling of deviations (Out-of-Specification results and complaints)
  • CAPA process
  • Measurement system analysis
  • Documentation
  • Retests
NIR (Near InfraRed Spectroscopy) for an Efficient
  • Control of Raw Materials
  • A short introduction to NIR Spectroscopy
  • NIR as a pharmacopoeial monograph
  • NIR for single container identification
  • Costs vs. benefit
  • NIR vs. ATR

WORKSHOP I Sampling

  • Examples for generating sample procedures
  • How to deal with the unexpected?
  • How to deal with deviations on the delivery?

WORKSHOP II Reduced Testing

Apart from any guidance, it is still much up to the manufacturer to decide which APIs and which excipients might be subject of a reduced testing procedure. Since the quality of the substance has to be assured without compromise, multiple factors must be considered before the full testing of every single batch can be reduced. It is the aim of this workshop to exchange information about different approaches and to discuss their advantages and disadvantages respectively considering the actual guidance as well as their practicability.

Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Übersicht nach Thema..

Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in einer themensortierten Liste.

Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
icon
Weitere Termine online
Weitere Termine online nicht verfügbar
icon
Aufzeichnung nicht verfügbar

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de

Frau mit Headset

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

"Die Umsetzung mit Memberspot ist wirklich ausgezeichnet gelungen.
Es unterstützt die Wissensvermittlung und gewährleistet auch die richtige Durchführung des Kurses.”
Christian Wagener, WAGENER & CO. GmbH
GMP Basis-Einstiegsschulung (B 1) - Aufzeichnung Online Seminar, April 2024

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023

„Interessante Themen, gut vorgetragen, die eigenen Erfahrungen der Vortragenden helfen, dies noch besser nachzuvollziehen.“ „Gute Gestaltung der Workshops, das Zusammenarbeiten in Gruppen und der Austausch mit anderen hilft sehr.“
Manuela Seibert, Merck, GMP-Leadauditor/in (FA 2), April 2024

NEWSLETTER

Bleiben Sie informiert mit dem GMP Newsletter von Concept Heidelberg!

GMP Newsletter

Concept Heidelberg bietet verschieden GMP Newsletter die Sie auf Ihren Bedarf hin zusammenstellen können.

Hier können Sie sich kostenfrei registrieren.

Kontakt

Kontaktieren Sie uns

Haben Sie Fragen?

Concept Heidelberg GmbH
Rischerstraße 8
69123 Heidelberg

Tel. :+49622184440
Fax : +49 6221 84 44 84
E-Mail: info@concept-heidelberg.de

zum Kontaktformular